GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » Deferred Policy Acquisition Costs

Codon AG (HAM:CNW) Deferred Policy Acquisition Costs


View and export this data going back to 1990. Start your Free Trial

What is Codon AG Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Codon AG (HAM:CNW) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » Deferred Policy Acquisition Costs
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.